PEMF Therapy to Treat Interstitial Cystitis/Bladder Pain Syndrome
Interstitial Cystitis, Chronic Interstitial Cystitis, Bladder Pain Syndrome
About this trial
This is an interventional treatment trial for Interstitial Cystitis focused on measuring Interstitial Cystitis, Bladder Pain Syndrome, Painful Bladder Syndrome, IC, BPS, Painful Bladder, Urinary urgency, Urinary frequency, Nocturia, Urinary incontinence
Eligibility Criteria
Inclusion Criteria:
- Female patients between 18 and 80 years old
- Participants must have already been diagnosed with interstitial cystitis/bladder pain syndrome
- Subjects must have a bladder capacity greater than 400 cc
- Participants must have scored at least a 6 or higher on Numeric Rating Scale questionnaire
- Participants must not have any cognitive disabilities
- Participants must not have taken any narcotic medication for at least three months before being enrolled in this clinical trial
Exclusion Criteria:
- Participants must not have any history of bladder, uterine, ovarian, or vaginal cancer, urethral diverticulum, spinal cord injury, stroke, Parkinson's disease, multiple sclerosis, spina bifida, radiation cystitis, cyclophosphamide treatment, or genital herpes
- Patients cannot have an implanted pace-maker or metal prosthesis
- Participants cannot have a urinary tract infection at the time of enrollment or be currently pregnant
- Patients must not have a body mass index greater than 40
Sites / Locations
- Wake Forest Health Sciences
Arms of the Study
Arm 1
Experimental
Treatment
Treatment will be provided via self-administration of pulsed electromagnetic field (PEMF) therapy using the B. Body (whole body mat), B. Pad (targeted pelvic mat), and Control Unit. The participant will lay the B. Body mat on any flat surface (i.e. floor, bed, reclining chair, etc.) and lie down on the mat with the smaller B. Pad placed directly over their pelvic area. Then, the participant will turn the PEMF device on using the attached control unit, which has been pre-programmed to deliver the same level of energy every time. Participants will be instructed to administer this home treatment twice a day (morning and evening) for 8-minute sessions over a four-week period. As this is a single-group assignment, all participants will be given the PEMF device.